β-Amyloid prevents excitotoxicity via recruitment of glial glutamate transporters

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 368, Issue 3, 2003, Pages 234-238

  Baba, Atsushi ^a   Mitsumori, Kazuhiko ^a   Yamada, Maki K ^a   Nishiyama, Nobuyoshi ^a   Matsuki, Norio ^a   Ikegaya, Yuji ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Alzheimer's disease; Amino acid transport system; Amyloid beta protein; Astrocytes; Cell death; Glutamic acid

Indexed keywords

AMYLOID BETA PROTEIN; GLUTAMATE TRANSPORTER; GLUTAMATE TRANSPORTER INHIBITOR; GLUTAMIC ACID; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; ASTROCYTE; BRAIN CELL; CELL INTERACTION; CELL LOSS; COCULTURE; CONTROLLED STUDY; CYTOTOXICITY; EMBRYO; GLIA CELL; NERVE CELL; NERVE CELL LESION; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PROTEIN FUNCTION; RAT; TOXICITY;

AMINO ACID TRANSPORT SYSTEM X-AG; AMYLOID BETA-PROTEIN; ANIMALS; ASPARTIC ACID; ASTROCYTES; CELLS, CULTURED; CEREBRAL CORTEX; COLORIMETRY; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMIC ACID; N-METHYLASPARTATE; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR;

EID: 0141958911     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-003-0792-6     Document Type: Article

References (27)

1. Abe K, Abe Y, Saito H (2000) Evaluation of L-glutamate clearance capacity of cultured rat cortical astrocytes. Biol Pharmaceut Bull 23:204-207
2. Brew H, Attwell D (1987) Electrogenic glutamate uptake is a major current carrier in the membrane of axolotl retinal glial cells. Nature 327:707-709
3. Chapman PF, White GL, Jones MW, Cooper-Blacketer D, Marshall VJ, Irizarry M, Younkin L, Good MA, Bliss TV, Hyman BT, Younkin SG, Hsiao KK (1999) Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat Neurosci 2:271-276
4. Chen G, Chen KS, Knox J, Inglis J, Bernard A, Martin SJ, Justice A, McConlogue L, Games D, Freedman SB, Morris RG (2000) A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease, Nature 408:975-979
5. Davies CA, Mann DM, Sumpter PQ, Yates PO (1987) A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease. J Neurol Sci 78:151-164
6. Fitzjohn SM, Morton RA, Kuenzi F, Rosahl TW, Shearman M, Lewis H, Smith D, Reynolds DS, Davies CH, Collingridge GL, Seabrook GR (2001) Age-related impairment of synaptic transmission but normal long-term potentiation in transgenic mice that overexpress the human APP695SWE mutant form of amyloid precursor protein. J Neurosci 21:4691-469
7. Forloni G, Angeretti N, Chiesa R, Monzani E, Salmona M, Bugiani O, Tagliavini F (1993) Neurotoxicity of a prion protein fragment. Nature 362:543-546
8. Horn D, Levy N, Ruppin E (1996) Neuronal-based synaptic compensation: a computational study in Alzheimer's disease. Neural Comput 8:1227-1243
9. Hsia AY, Masliah E, McConlogue L, Yu GQ, Tatsuno G, Hu K, Kholodenko D, Malenka RC, Nicoll R, Mucke L (1999) Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc Natl Acad Sci USA 96: 3228-3233
10. Ikegaya Y, Matsuura S, Ueno S, Baba A, Yamada MK, Nishiyama N, Matsuki N (2002) β-Amyloid enhances glial glutamate uptake activity and attenuates synaptic efficacy. J Biol Chem 277:32180-32186
11. Kamenetz F, Tomita T, Hsieh H, Seabrook G, Borchelt D, Iwatsubo T, Sisodia S, Malinow R (2003) APP processing and synaptic function. Neuron 37:925-937
12. Kanai Y, Smith CP, Hediger MA (1993) A new family of neurotransmitter transporters: the high-affinity glutamate transporters. FASEB J 7:1450-1459
13. Larson J, Lynch G, Games D, Seubert P (1999) Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice. Brain Res 840: 23-35
14. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, Wals P, Zhang C, Finch CE, Krafft GA, Klein WL (1996) Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 95:6448-6453
15. Matsuura S, Ikegaya Y, Yamada MK, Nishiyama N, Matsuki N (2002) Endothelin downregulates the glutamate transporter GLAST in cAMP-differentiated astrocytes in vitro. Glia 37:178-182
16. Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, Rydel RE (1992) β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 12:376-389
17. Moechars D, Dewachter I, Lorent K, Reverse D, Baekelandt V, Naidu A, Tesseur I, Spittaels K, Haute CV, Checler F, Godaux E, Cordell B, Van Leuven F (1999) Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J Biol Chem 274:6483-6492
18. Nitta A, Itoh A, Hasegawa T, Nabeshima T (1994) β-Amyloid protein-induced Alzheimer's disease animal model. Neurosci Lett 170:63-66
19. Oleny JW (1989) Excitatory amino acids and neuropsychiatric disorders. Biol Psychiatry 26:505-525
20. Ruppin E, Reggia JA (1995) A neural model of memory impairment in diffuse cerebral atrophy. Br J Psychiatry 166:19-28
21. Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Liao Z, Lieberburg I, Motter R, Mutter L, Soriano F, Shopp G, Vasquez N, Vandevert C, Walker S, Wogulis M, Yednock T, Games D, Seubert P (1999) Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400:173-177
22. Selkoe DJ (2002) Alzheimer's disease is a synaptic failure. Science 298:789-791
23. Small DH, McLean CA (1999) Alzheimer's disease and the amyloid β protein: what is the role of amyloid? J Neurochem 73: 443-449
24. Small DH, Mok SS, Bornstein JC (2001) Alzheimer's disease and Aβ toxicity: from top to bottom. Nat Rev Neurosci 2:595-598
25. Stéphan A, Laroche S, Davis S (2001) Generation of aggregated β-amyloid in the rat hippocampus impairs synaptic transmission and plasticity and causes memory deficits. J Neurosci 21:5703-5714
26. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R (1991) Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30:572-580
27. Yankner BA, Duffy LK, Kirschner DA (1990) Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science 250:279-282